New York State declares a disaster emergency over monkeypox outbreak Impact on pcr consumables
New York state has declared a disaster emergency over an outbreak of monkeypox
impacts on the pcr consumables
New York's rapidly spreading monkeypox outbreak was declared a state disaster emergency late on Friday by Governor Kathy Hochul, as authorities raced to distribute vaccines to contain the spread of the virus. The measure comes as the number of monkeypox infections in New York approaches 1,400, with most of the infections in the city. New York City is the epicenter of the monkeypox outbreak in the United States
"With more than a quarter of monkeypox cases in this country occurring in New York State, we need to respond with every tool in our Arsenal," Hochul said of the emergency declaration in a statement. The head of the World Health Organization declared the virus a global health emergency late last week. As of Wednesday, more than 20,000 cases of monkeypox had been detected in 77 countries worldwide. There are now about 4,600 reported cases in the United States, according to USA Today.
The executive order specifically expands the pool of eligible individuals who can be vaccinated against monkeypox to include emergency medical service workers, pharmacists and midwives. It also allows physicians and registered nurse practitioners to issue standing orders for non-patient-specific vaccines and requires providers to send vaccine data to state health departments.
Meanwhile, the mayor of San Francisco declared a state of emergency in the city on Thursday due to the growing number of cases in the city. There have been 800 cases in California and 261 in San Francisco. "We desperately need vaccines to support the people of San Francisco," London Mayor Breed said. Federal health officials say they are still considering whether to declare monkeypox a public health emergency, which would free up additional resources.
After the federal government struggled to get enough monkeypox vaccine earlier this month, supplies have climbed steadily in recent weeks, peaking on Friday with 780,000 doses distributed nationwide. About 110,000 doses were sent to New York, including about 30,000 doses outside the city. Earlier this week, vaccine clinics in the greater New York area, as well as several upstate counties, faced huge demand because of limited vaccine supplies, as people booked appointments within hours.
Healthcare workers from the New York City Department of Health and Mental Hygiene help people register for the monkeypox vaccine at a vaccination site in New York City on July 26, 2022. On July 29, New York declared a statewide disaster emergency due to monkeypox. Based on previous outbreaks of monkeypox around the world, some groups may also be at increased risk of severe consequences if infected. This includes people with weakened immune systems, older New Yorkers, children under the age of 8 and pregnant women.
Overview of market area prospect of
By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). North America is further divided into countries such as the United States and Canada. The European region is further divided into The United Kingdom, France, Germany, Italy, Spain, Russia and the rest of Europe. The Asia Pacific region is further subdivided into China, Japan, Korea, India, Australia, Southeast Asia and the rest of Asia Pacific. The Latin America region is further subdivided into Brazil, Mexico and the rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa and the rest of MEA.
Buy high quality and effective DNA & RNA
nucleic acid extraction
reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables
or pcr consumables
. Send an email to:
and our professional sales engineer will get back to you within 48 hours.
Analysis and forecast of the market size of PCR diagnostic industry
Polymerase chain reaction (PCR) is a nucleic acid synthesis technology that uses the principle of DNA double-strand replication to replicate specific DNA fragments in vitro. With this technology, the detection equipment can amplify the target gene in a large number in a short time, expanding the target gene fragment to the order of millions to billions, thus achieving high sensitivity detection. At present, polymerase chain reaction (PCR) diagnosis of infectious diseases such as hepatitis, venereal disease, intestinal respiratory disease and tumor single gene detection is an important application field. In 2020, polymerase chain reaction (PCR) diagnostic technology was identified as the "gold standard" for COVID-19 diagnosis due to its high sensitivity and accuracy.
China's PCR diagnostic market is developing rapidly, with the market size growing rapidly from about RMB 2.37 billion in 2015 to about RMB 5.93 billion in 2019, with a compound annual growth rate of 25.8%. China's PCR industry experienced explosive growth due to the huge demand for testing caused by the outbreak of COVID-19 in 2020, and the market size of China's PCR diagnostic industry exceeded 10 billion yuan in 2020. With the introduction of a large number of PCR diagnostic instruments, the PCR diagnostic industry will enter a new stage of development. It is expected that the PCR diagnostic industry will maintain a double-digit growth rate, and the market size of the PCR diagnostic industry will reach about 23.42 billion yuan in 2030 based on the factory price, and the cagR will reach about 13.3% from 2019 to 2030.
Market Demand of
The DNA/RNA Extraction Kit market and other
s are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.
The COVID-19 pandemic has impacted the
market for a short time due to restrictions on different business and research activities for
s. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.
Market drivers for
The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.
Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.
North America is expected to dominate the global
market during the forecast period
North America, which holds a major share in the
market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.
In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for
s, and the rising prevalence of chronic diseases.
The pcr consumables professional supplier manufacturer -Geneture
is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier.
Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.
Feel free to get a qutoe
send an email
and our professional sales engineer will get back to you within 48 hours.